Search | Page 4 | ASTRO

From Beam to Bedside: Benefits and Logistics of a Dedicated Palliative Radiation Therapy Service
Pharmacologic Symptom Management in the Radiation Oncology Clinic
Challenges in Breast Cancer Management: Recurrent Disease, Reconstruction and Hypofractionation
Practical Management Strategies for Advanced Stage Gynecologic Cancer Patients
Managing Radiotherapy-Induced Symptoms: Practical Evidence-Based Strategies for the Radiation Oncologist
Emerging Indications for Radiation in Poly-Metastatic Cancers
Liquid Biopsies in Cancer
Integration of Minimally Invasive Interventional Procedures with Palliative Radiation Therapy
Raising the Bar and Lowering Uncertainties in Reirradiation
Radiotherapy for Leukemia: Past, Present and Future
ROBIN Oligometastasis (OligoMET) Center: Using Biomarker Correlates from a Prostate Cancer Clinical Trial to Improve Future Outcomes
Techniques and Applications of Synthetic Images
Management of Locally Recurrent Head and Neck Cancer
The Journey of the Unknown Primary in the HPV Era: Evaluation, Treatment, Surveillance and Management of Oligometastatic Disease
Providing Equitable Care to Pregnant Patients
Disparities in Gynecologic Cancer Care and Outcomes in the Age of Molecular Profiling and Targeted Therapies: Etiologies and Solutions
Palliative Radiation Therapy for Spine Metastases
Navigating the Complexities of Brain Metastases and Leptomeningeal Disease Management
New Tools for Formidable Foes: Strategies for Management of Unresected Soft Tissue Sarcomas
To Radiate or Not to Radiate? Updates to Management of Retroperitoneal Sarcoma
Radiation as an Immune Catalyst: Techniques, Biology and Biomaterials for Enhancing Tumor Control
ASTRO/KCA Joint Activity: Stereotactic Radiotherapy and Renal Cell Cancer, Overcoming Radioresistance and the Resistance to Radiate
Designing, Implementing and Interpreting Patient Reported Outcomes in Clinical Investigation
Contemporary Multi-Disciplinary Management of Bladder Cancer
ASTRO/ILROG Joint Activity: The Comeback of RT – Radiation Therapy is Back in the Frontline of Managing Hodgkin and Indolent Lymphomas

Pages